Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA
Firm Income Reported for This Client
$190K
Not substituted for client expenses
Summary
DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA is an organization, based in NY. Its political footprint includes $190K in lobbying-firm income reported for this client. Lobbying activity focuses on Budget/Appropriations, Medical/Disease Research/Clinical Labs. Political activity spans from 2022 to 2026.